Swati Mukherjee, et al. In Vivo Proof of Concept for EDIT-102: A CRISPR/Cas9-Based Experimental Medicine for USH2A-Related Inherited Retinal Degeneration Caused by Mutations in Exon 13. Presented at the 23rd ASGCT Annual Meeting, May 12-15, 2020.

Feb

28

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates

Feb

21

Editas Medicine Announces Fourth Quarter and Full Year 2023 Results Conference Call and Upcoming Investor Events

Jan

31

Editas Medicine to Participate in Upcoming Investor Conferences